Photo by schluditsch from unsplash
Whether non-thienopyridines may protect patients more efficiently from microembolic events during TAVI has not been investigated. We hypothesized that ticagrelor+ASA will reduce the number of microemboli towards the cerebral circulation… Click to show full abstract
Whether non-thienopyridines may protect patients more efficiently from microembolic events during TAVI has not been investigated. We hypothesized that ticagrelor+ASA will reduce the number of microemboli towards the cerebral circulation during TAVI comparing to the combination of clopidogrel+ASA.
Keywords:
role reduction;
platelet inhibition;
drug related;
inhibition role;
microemboli;
related platelet
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!